Clinical Trial Update: The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated potential pharmacokinetic interactions when oral casopitant is co-administered with oral dolasetron, granisetron, or rosiglitazone …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Dolasetron (dolasetron)
• Granisetron (granisetron)
• Rosiglitazone (rosiglitazone)
• casopitant (casopitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nausea and Vomiting, Chemotherapy-Induced | Phase 1 | Status: COMPLETED